Clinical Trial Update: Methylation Biomarkers for Pioneering Early Esophageal Cancer Detection

View source ↗

Summary

A completed clinical trial by Singlera Genomics evaluating methylation biomarkers for early detection of esophageal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Snippet

Sponsor: Singlera Genomics Inc. | Conditions: Esophageal Cancer | Status: COMPLETED